Crestone Asset Management LLC Invitae Corp Transaction History

Crestone Asset Management LLC

  • $497 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 05, 2021
SELL
$24.31 - $33.6 $22,195 - $30,676
-913 Reduced 3.28%
26,958 $766,000
Q2 2021

Aug 02, 2021
SELL
$26.09 - $40.4 $236,845 - $366,751
-9,078 Reduced 24.57%
27,871 $940,000
Q1 2021

Apr 27, 2021
BUY
$33.06 - $56.93 $1.22 Million - $2.1 Million
36,949 New
36,949 $1,000

Others Institutions Holding NVTA

# of Institutions
56
Shares Held
7.66M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Crestone Asset Management LLC Portfolio

Follow Crestone Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crestone Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crestone Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email